HR Execs on the Move


 
Ranfac provides contracted certified sterilization validation services that meet current requirements for each form of sterilization. We can provide turnkey product validation with all necessary documentation, product sample submissions and quarterly
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

S.A.F.T.E. (Safety Alert for the Elderly)

S.A.F.T.E. (Safety Alert for the Elderly) is a Pleasanton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ConcertoCare

ConcertoCare is one of the nation`s leading risk-based health care companies focused on providing integrated care for seniors where they are best served: in their homes. ConcertoCare`s programs are designed for seniors with the same core, in-home care model and composed collaboratively with patients. The ConcertoCare model improves overall health quality and outcomes with a proven track record of reducing hospital admits by 47%, readmits by 40% and ER visits by 16% while achieving an increase of 38% in annual wellness visits for the most vulnerable patient populations in the U.S., benefiting patients, payers and provider networks alike. The programs are supported by a combination of in-home medical, behavioral and social services and enhanced via advanced proprietary technologies.

HealthWorks

HealthWorks is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Chandler Group

Chandler Group is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Envisia Therapeutics

Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.